Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
March 29, 2018
Homology Medicines Announces Pricing of Initial Public Offering
March 22, 2018
Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec To Manufacture Universal Donor Cell Therapies
March 21, 2018
CIDARA THERAPEUTICS PROVIDES CLINICAL DATA UPDATES FOR ITS LEAD ANTIFUNGAL REZAFUNGIN
March 20, 2018
FOLLOWING ITS BLUEPRINT: IDEAYA BIOSCIENCES
March 19, 2018
Take This App and Call Me in the Morning – A look at Pear Therapeutics’ digital reSet Application
March 19, 2018
CIDARA THERAPEUTICS REPORTS POSITIVE TOPLINE RESULTS FROM PHASE 2 STRIVE TRIAL OF LEAD ANTIFUNGAL REZAFUNGIN
March 15, 2018
IDEAYA Biosciences Raises $94 Million Crossover Series B Financing
March 13, 2018
IDEAYA Biosciences and Cancer Research UK Announce Partnership Agreement to Develop Small Molecule Inhibitors of PARG
March 13, 2018
IDEAYA Biosciences Appoints Julie Hambleton, M.D., as Senior Vice President and Chief Medical Officer, Head of Development
March 13, 2018
CRINETICS PHARMACEUTICALS COMPLETES $63.5 MILLION SERIES B FINANCING
« Previous Page
1
…
6
7
8
9
10
Next Page »